FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

AI justification

FDA approval of life-changing gene therapy for genetic hearing loss under national priority program. | The FDA's approval of a groundbreaking gene therapy for genetic hearing loss represents a significant advancement in medical treatment, directly improving health outcomes (SDG 3) and fostering innovation (SDG 9). The National Priority Voucher Program further incentivizes rare disease therapies, aligning with public health priorities. No discernible ethical violations or negative consequences ar